ATP2A1 and congenital myopathy: These findings indicate that Brody myopathy, along with genetic analysis of ATP2A1, should be considered in patients with clinical myotonia of unclear etiology, as well as patients who have findings suggestive of congenital myopathy on muscle biopsy.